-
Sector Analysis
Phenylketonuria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in Phenylketonuria Therapeutics. - GlobalData epidemiologists estimate that there were 498,757 diagnosed prevalent cases of Phenylketonuria in 2024, which is expected to increase slightly to 557,730 diagnosed prevalent cases by 2029. - PKU is managed through a combination of supportive care, chemotherapy, and targeted therapies. - The PKU pipeline holds 262 molecules, with two assets in the pre-registration stage, 16 assets in Phase III development, and 87...
-
Sector Analysis
The Far-Reaching Impact of US Foreign Aid Cuts
The Trump administration's ruthless cuts to foreign aid funding has sparked major global health concerns and uncertainty about the future of essential programs and disease prevention efforts in developing countries.
-
Sector Analysis
Poland's Medical Fund and the Accelerated Reimbursement Mechanism for Orphan and Oncology Drugs in 2021-2025: Small Gains and an Uncertain Future
Four years on from the implementation of the Medical Fund Act, GlobalData takes a look at the impact it has had on the availability of new, innovative therapies in Poland during this period.
-
Product Insights
Type 1 Diabetes (Juvenile Diabetes) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) - Global Clinical Trials Review, 2025" provides an overview of Type 1 Diabetes (Juvenile Diabetes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Type 1 Diabetes (Juvenile Diabetes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Acute Decompensated Heart Failure Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025" provides an overview of Acute Decompensated Heart Failure Clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Decompensated Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Erythrodermic Psoriasis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Erythrodermic Psoriasis - Global Clinical Trials Review, 2025" provides an overview of Erythrodermic Psoriasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Erythrodermic Psoriasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Alpha-1 Antitrypsin Deficiency Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Alpha-1 Antitrypsin Deficiency (A1AD) - Global Clinical Trials Review, 2025" provides an overview of Alpha-1 Antitrypsin Deficiency (A1AD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Alpha-1 Antitrypsin Deficiency (A1AD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Tuberculosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Tuberculosis - Global Clinical Trials Review, 2025" provides an overview of Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Actinic (Solar) Keratosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025" provides an overview of Actinic (Solar) Keratosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Actinic (Solar) Keratosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Pulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Pulmonary Fibrosis - Global Clinical Trials Review, 2025" provides an overview of Pulmonary Fibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.